# Atropine Eye Drops for Watery Eyes (Excessive Tearing)

> **NCT07676981** · PHASE2 · COMPLETED · sponsor: **Rehan Ahmed** · enrollment: 18 (actual)

## Conditions studied

- Epiphora

## Interventions

- **DRUG:** Atropine ophthalmic solution

## Key facts

- **NCT ID:** NCT07676981
- **Lead sponsor:** Rehan Ahmed
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2026-06-16
- **Primary completion:** 2026-07-06
- **Final completion:** 2026-07-15
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2026-09-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07676981

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07676981, "Atropine Eye Drops for Watery Eyes (Excessive Tearing)". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07676981. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*